Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | -1.27% | +9.06% | -22.28% |
06/05 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.28% | 130M | |
+26.02% | 49.18B | |
+0.70% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+12.88% | 26.09B | |
-21.90% | 18.71B | |
+9.27% | 13.26B | |
+31.06% | 12.32B | |
-0.34% | 11.99B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Omega Therapeutics Study of OTX-2002 Shows High Engagement With Patients, Without Dose-Limiting Toxicities